Background The efficacy and safety of thromboprophylaxis in patients with acute medical
illnesses who may be at risk for venous thromboembolism have not been determined in …

Abstract The Medical Patients with Enoxaparin (MEDENOX) trial was a randomized, placebo-
controlled study that defined the risk of venous thromboembolism (VTE) in acutely ill …

The clinical benefit and cost-effectiveness of routine thromboprophylaxis in surgical patients
has been well documented, but use of this approach in general medical patients remains …

Background: Venous thromboembolism (VTE) prophylaxis in medically ill patients has
received a level 1A recommendation in previously published clinical guidelines …

Background—Considerable variability exists in the use of pharmacological
thromboprophylaxis among acutely ill medical patients, partly because clinically relevant …

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality in
hospitalized patients with acute medical illness. The high prevalence of VTE in this patient …

Background The efficacy and safety of prolonging prophylaxis for venous thromboembolism
in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that …

Objectives. Venous thromboembolism (VTE) is a potentially serious complication of
hospitalization and immobilization. The use of anticoagulant prophylaxis in acutely ill …

Background Although thromboprophylaxis reduces the incidence of venous
thromboembolism in acutely ill medical patients, an associated reduction in the rate of death …

Given the increased number of patients hospitalized for acute medical illnesses and the
associated risk of venous thromboembolism (VTE), the use of prophylaxis has become a …